GKB Ophthalmics Ltd — Others, 22-08-2025: AGM/EGM

GKB Ophthalmics shareholders have approved all 10 resolutions at the company's 43rd Annual General Meeting. Key approvals include adopting the Standalone and Consolidated Financial Statements for the financial year ended March 31, 2025, and re-appointing Mr. Cedric Lobo as a Director. Shareholders also sanctioned revised and new Material Related Party Transactions for FY2025-26 and FY2026-27, encompassing both the company and its subsidiaries. Further, approvals were given for appointing a Secretarial Auditor, a related party holding office in a subsidiary, increasing the company's borrowing limit, and creating charges on assets.